The mid-size pharmaceutical market in Europe is expected to grow from US$ 201,707.89 million in 2022 to US$ 288,168.27 million by 2028; it is estimated to grow at a CAGR of 6.1% from 2022 to 2028.
The mid-size pharmaceutical market in Europe is characterized by the presence of various market players. To increase their market share, the players adopt various strategies such as product launches, regional expansion, and technological advancements. Leading players invest in R&D to develop advanced technologies and gain revenue. Europe accounts for the second-largest market share and is anticipated to register a significant growth rate over the forecast period. The market growth in this region is attributed to the increasing number of product launches and the growing prevalence of chronic diseases. Further, increased government expenditures on the healthcare sector favor the entry of new players in the mid-size pharmaceutical market in this region. However, the cutthroat competition among market players hinders the market growth.
By introducing new features and technologies, vendors in the Europe mid-size pharmaceutical market can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the market growth at a good CAGR during the forecast period.
Europe Mid-Size Pharmaceutical Market Segmentation
The Europe mid-size pharmaceutical market is segmented on the basis of type, drug development type, formulation, therapy class, and country.
Based on type, the Europe mid-size pharmaceutical market is bifurcated into prescription and over-the-counter. In 2022, the over-the-counter segment accounted for a larger market share. Based on drug development type, the market is bifurcated into in-house and outsource. The outsource segment held a larger market share in 2022. Based on formulation, the Europe mid-size pharmaceutical market is segmented into tablets and capsules, injectables, sprays, and other formulations. The tablets & capsules segment held the largest market share in 2022. Based on therapy class, the market is segmented into cardiovascular diseases, pain management, diabetes, cancer, and other conditions. The diabetes segment held the largest market share in 2022. Based on country, the Europe mid-size pharmaceutical market is segmented into Germany, France, the UK, Italy, Spain, and Rest of Europe. Germany held the largest market share in 2022.
Alexion Pharmaceuticals, Inc.; Bausch Health Companies Inc.; Daiichi Sankyo Company Limited; Eisai Co., Ltd.; Endo Pharmaceuticals Inc.; Les Laboratories Servier; Mallinckrodt; Regeneron Pharmaceuticals, Inc; Sun Pharmaceutical Industries Ltd; and UCB S.A. are among the leading companies operating in the mid-size pharmaceutical market in the region.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 201,707.89 Million |
| Market Size by 2028 | US$ 288,168.27 Million |
| CAGR (2022 - 2028) | 6.1% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Mid-Size Pharmaceutical Market is valued at US$ 201,707.89 Million in 2022, it is projected to reach US$ 288,168.27 Million by 2028.
As per our report Europe Mid-Size Pharmaceutical Market, the market size is valued at US$ 201,707.89 Million in 2022, projecting it to reach US$ 288,168.27 Million by 2028. This translates to a CAGR of approximately 6.1% during the forecast period.
The Europe Mid-Size Pharmaceutical Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Mid-Size Pharmaceutical Market report:
The Europe Mid-Size Pharmaceutical Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Mid-Size Pharmaceutical Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Mid-Size Pharmaceutical Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Mid-Size Pharmaceutical Market
